M. Sayiner, A. Koenig, L. Henry, and Z. M. Younossi, “Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World,” Clin Liver Dis, vol. 20, no. 2, pp. 205–214, May 2016, doi: 10.1016/J.CLD.2015.10.001.

G. C. Farrell and C. Z. Larter, “Nonalcoholic fatty liver disease: From steatosis to cirrhosis,” Hepatology, vol. 43, no. 2 SUPPL. 1, Feb. 2006, doi: 10.1002/HEP.20973.

H. Yki-Järvinen, “Diagnosis of non-alcoholic fatty liver disease (NAFLD),” Diabetologia, vol. 59, no. 6, pp. 1104–1111, Jun. 2016, doi: 10.1007/S00125-016-3944-1/FIGURES/2.

G. Targher, M. B. Chonchol, and C. D. Byrne, “CKD and nonalcoholic fatty liver disease,” American Journal of Kidney Diseases, vol. 64, no. 4, pp. 638–652, Oct. 2014, doi: 10.1053/j.ajkd.2014.05.019.

A. P. Evan, “Physiopathology and etiology of stone formation in the kidney and the urinary tract,” Pediatric Nephrology, vol. 25, no. 5, pp. 831–841, May 2010, doi: 10.1007/S00467-009-1116-Y/TABLES/1.

Y. Kohjimoto, A. Iba, Y. Sasaki, and I. Hara, “[Metabolic syndrome and nephrolithiasis].,” Hinyokika Kiyo, vol. 57, no. 1, pp. 43–7, Jan. 2011.

S. K. Abdulqader, Y. A. A. Al-Ani, N. N. Akram, W. Nori, and M. Al-Kinani, “Metastatic Ovarian Tumor from Incidental Renal Cell Carcinoma: A Case Report and Literature Review,” Al- Anbar Medical Journal, vol. 20, no. 1, pp. 113–116, Jun. 2024, doi: 10.33091/AMJ.2024.145878.1521.

Zhang, Y. N., Fowler, K. J., Hamilton, G., Cui, J. Y., Sy, E. Z., Balanay, M., ... & Sirlin, C. B. (2018). Liver fat imaging—a clinical overview of ultrasound, CT, and MR imaging. The British journal of radiology, 91(1089), 20170959.

G. Marchesini et al., “Nonalcoholic Fatty Liver DiseaseA Feature of the Metabolic Syndrome,” Diabetes, vol. 50, no. 8, pp. 1844–1850, Aug. 2001, doi: 10.2337/DIABETES.50.8.1844.

A. Lonardo, S. Ballestri, G. Marchesini, P. Angulo, and P. Loria, “Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome,” Digestive and Liver Disease, vol. 47, no. 3, pp. 181–190, Mar. 2015, doi: 10.1016/J.DLD.2014.09.020/ATTACHMENT/DBA4BF32-60E4-4630-9148-E71A56C50AB3/MMC1.DOC.

G. Marchesini et al., “Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome,” Hepatology, vol. 37, no. 4, pp. 917–923, Apr. 2003, doi: 10.1053/JHEP.2003.50161.

P. Dietrich and C. Hellerbrand, “Non-alcoholic fatty liver disease, obesity and the metabolic syndrome,” Best Pract Res Clin Gastroenterol, vol. 28, no. 4, pp. 637–653, Aug. 2014, doi: 10.1016/J.BPG.2014.07.008.

Y. V. Wong, P. Cook, and B. K. Somani, “The Association of Metabolic Syndrome and Urolithiasis,” Int J Endocrinol, vol. 2015, no. 1, p. 570674, Jan. 2015, doi: 10.1155/2015/570674.

B. Einollahi, M. R. Naghii, and M. Sepandi, “Association of nonalcoholic fatty liver disease (NAFLD) with urolithiasis,” Endocr Regul, vol. 47, no. 1, pp. 27–32, 2013, doi: 10.4149/ENDO_2013_01_27.

K. Khaliq Bhinder, “DECIPHERING THE ASSOCIATION BETWEEN TYPE OF RENAL STONES AND HEPATIC FATTY INFILTRATION; A RETROSPECTIVE SINGLE INSTITUTE STUDY A L O F R A D I O LO GY.”

P. Schwille, A. Schmiedl, and J. Wipplinger, “Idiopathic Recurrent Calcium Urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation*,” European Journal of Medical Research 2009 14:9, vol. 14, no. 9, pp. 378–392, Sep. 2009, doi: 10.1186/2047-783X-14-9-378.

J. Carrasco-Valiente et al., “Estado de los marcadores de fase aguda y estrés oxidativo en los enfermos con litiasis de la vía urinaria,” Actas Urol Esp, vol. 36, no. 5, pp. 296–301, May 2012, doi: 10.1016/J.ACURO.2011.08.004.

S. Kim et al., “Non-alcoholic fatty liver disease and the development of nephrolithiasis: A cohort study,” PLoS One, vol. 12, no. 10, p. e0184506, Oct. 2017, doi: 10.1371/JOURNAL.PONE.0184506.

A. Heidenreich, F. Desgrandschamps, and F. Terrier, “Modern Approach of Diagnosis and Management of Acute Flank Pain: Review of All Imaging Modalities,” Eur Urol, vol. 41, no. 4, pp. 351–362, Apr. 2002, doi: 10.1016/S0302-2838(02)00064-7.

T. Niemann, T. Kollmann, and G. Bongartz, “Diagnostic performance of low-dose CT for the detection of urolithiasis: A meta-analysis,” American Journal of Roentgenology, vol. 191, no. 2, pp. 396–401, Nov. 2008, doi: 10.2214/AJR.07.3414/ASSET/IMAGES/08_07_3414_04.JPEG.

I. C. Nam, “Association of non-alcoholic fatty liver disease with renal stone disease detected on computed tomography,” Eur J Radiol Open, vol. 3, p. 195, Jan. 2016, doi: 10.1016/j.ejro.2016.07.004.

M. Sametzadeh, M. G. Hanafi, Z. Fazelinejad, M. H. Haghighizadeh, and M. Kheradmand, “Association between Non-alcoholic Fatty Liver Disease and Renal Stone Formation Based on Sex and Age,” GOVARESH, vol. 27, no. 4, pp. 250–256, Mar. 2023, Accessed: Jul. 20, 2024. [Online]. Available: http://govaresh.org/index.php/dd/article/view/2570

D. Paz and L. Guralnik, “Association of renal stone (urolithiasis) with nonalcoholic fatty liver (NAFL),” 2015, doi: 10.1594/ECR2015/C-2056.